Summary
The effects of mazindol, amphetamine and fentluramine on uptake and release of 3H-DA by synaptosomes were studied in different systems.
In in vitro incubations of 3H-DA with synaptosomes isolated from the caudate nucleus of the rat, mazindol inhibited the uptake of the radioactivity more potently than did amphetamine.
When the synaptosomes were isolated from the caudate nuclei of rats treated in vivo with either mazindol or amphetamine, the uptake of 3H-DA during in vitro incubation was lower with synaptosomes of amphetamine-treated rats than with those of mazindol-treated rats.
When synaptosomes of untreated rats were prelabelled with 3H-DA and incubated in the presence of amphetamine or of mazindol, amphetamine caused a greater releaseoof radioactivity than did mazindol.
Fenfluramine was without activity in all these systems.
In spite of the quantitative differences, both amphetamine and mazindol appear to have similar effects on uptake and release of dopamine, and this may account for their analogous pharmacological profile.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahlenius, S., Engel, J.: Behavioral and biochemical effects of l-Dopa after inhibition of dopamine-β-hydroxylase in reserpine pretreated rats. Naunyn-schmiedebergs Arch. Pharmak. 270, 349–360 (1971)
Andén, N. E., Dahlstrom, A., Fuxe, K., Larsson, K., Olsson, L., Ungerstedt, U.: Ascending monoamine neurons to the telencephalon and diencephalon. Acta physiol. scand. 67, 313–326 (1966)
Beaz, L. A.: Role of catecholamines in the anorectic effects of amphetamine in rats. Psychopharmacologia (Berl.) 35, 91–98 (1974)
Bertler, A., Rosengren, E.: Occurrence and distribution of catecholamines in the brain. Acta physiol. scand. 47, 350–357 (1959a)
Bertler, A., Rosengren, E.: Occurrence and distribution of dopamine in brain and other tissues. Experientia (Basel) 15, 10–11 (1959b)
Carlsson, A., Fuxe, K., Hamberger, B., Lindquist, M.: Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta physiol. scand. 67, 481–497 (1966)
Carruba, M. O., Groppetti, A., Mantegazza, P., Vicentini, L., Zambotti, F.: Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate. Brit. J. Pharmacol. 56, 431–436 (1976)
Clineschmidt, B. V.: 5,6-Dihydroxytryptamine: suppression of the anorexigenic action of fenfluramine. Europ. J. Pharmacol. 24, 405–409 (1973)
Clineschmidt, B. V., McGuffin, C., Werner, A. R.: Role of monoamines in the anorexigenic action of fenfluramine, amphetamine and p-chloromethamphetamine. Europ. J. Pharmacol. 27, 313–323 (1974)
Coyle, J. T., Snyder, S. H.: Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different area. J. Pharmacol. exp. Ther. 170, 221–231 (1969)
Duncan, E. H., Hyde, C. A., Regan, N. A., Sweetman, B.: A preliminary trial of fenfluramine in general practice. Brit. J. clin. Pract. 19, 451–452 (1965)
Ernst, A. M.: The role of biogenic amines in the extrapyramidal system. Acta physiol. pharmacol. neer. 15, 141–154 (1969)
Fibiger, H. C., Zis, A. P., Mc Geer, E. G.: Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: similarities to the lateral hypothalamic syndrome. Brain Res. 55, 135–148 (1973)
Fog, R., Randrup, A., Pakkenberg, N.: Lesion in corpus striatum and cortex in rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behavior. Psychopharmacologia (Berl.) 18, 346–356 (1970)
Funderburk, W. H., Hazelwood, J. C., Ruckart, R. T., Ward, J. W.: Is 5-hydroxytryptamine involved in the mechanism of action of fenfluramine? J. Pharm. Pharmacol. 23, 468–469 (1971)
Fuxe, K., Ungerstedt, U.: Histochemical, biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration. In: Amphetamines and related compounds (E. Costa and S. Garattini, eds.), pp. 257–288. New York: Raven Press 1970
Glowinski, J.: Effect of amphetamine on various aspects of catecholamine metabolism in the central nervous system of the rat. In: Amphetamines and related compounds (E. Costa and S. Garattini, eds.), pp. 301–316. New York? Raven Press 1970
Glowinski, J., Axelrod, J.: Effects of drugs on the uptake, release and metabolism of 3H-norepinephrine in the rat brain. J. Pharmacol. exp. Ther. 149, 43–49 (1965)
Glowinski, J., Axelrod, J., Iversen, L.: Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of 3H-norepinephrine and 3H-dopamine. J. Pharmacol. exp. Ther. 153, 30–42 (1966)
Groppetti, A., Zambotti, F., Biazzi, A., Mantegazza, P.: Amphetamine and cocaine on amine turnover. In: Frontiers in catecholamine research (E. Usdin and S. H. Snyder, eds.), pp. 917–925. Oxford: Pergamon Press 1973
Jespersen, S., Scheel-Krüger, J.: Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia. J. Pharm. Pharmacol. 25, 49–54 (1973)
Kannengiesser, M. H., Hunt, P. F., Raynaud, J. P.: Comparative action of fenfluramine on the uptake and release of serotonin and dopamine. Europ. J. Pharmacol. 35, 35–43 (1976)
Kruk, Z. L.: Dopamine and 5-hydroxy-tryptamine inhibit feeding in rats. Nature New Biol. 246, 52–53 (1973)
Le Douarec, J. C., Schmitt, H.: Comparison pharmacologique de sept medicaments anorexigenes. Thérapie 19, 831–841 (1964)
Lemberger, L., Witt, E. D., Davis, J. M., Kopin, I. J.: The effect of haloperidol and chlorpromazine on amphetamine metabolism and amphetamines stereotyped behavior in the rat. J. Pharmacol. exp. Ther. 174, 428–433 (1970)
Lowry, O. H., Rosebrough, H. J., Farr, A. L., Randall, R. J.: Protein measurement with the folin phenol reagent. J. biol. Chem. 193, 265–275 (1951)
Moore, K. E., Carr, L. A., Dominic, J. A.: Functional significance of amphetamine-induced release of brain catecholamines. In: Amphetamines and related compounds (E. Costa and S. Garattini, eds.), pp. 371–384. New York: Raven Press 1970
Randrup, A., Munkvad, I.: Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamines. In: Amphetamines and related compounds (E. Costa and S. Garattini, eds.), pp. 695–713. New York: Raven Press 1970
Randrup, A., Scheel-Krüger, J.: Diethyldithiocarbamate and amphetamine stereotyped behaviour. J. Pharm. Pharmacol. 18, 752 (1966)
Samanin, R., Ghezzi, D., Valzelli, L., Garattini, S.: The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine. Europ. J. Pharmacol. 19, 318–322 (1972)
Samanin, R., Bernasconi, S., Garattini, S.: The effect of selective lesioning of brain catecholamine-containing neurons on the activity of various anorectics in the rat. Europ. J. Pharmacol. 34, 373–375 (1975)
Tseng, L. F., Walaszek, E. J.: Blockade of d-amphetamine-induced stereotyped behavior by bulbocapnine. Pharmacology (Basel) 7, 255–258 (1972)
Zambotti, F., Carruba, M. O., Barzaghi, F., Vicentini, L., Groppetti, A., Mantegazza, P.: Behavioural effects of a new nonphenylethylamine anorexigenic agent: Mazindol. Europ. J. Pharmacol. 36, 405–412 (1976)
Ziance, R. J., Buckley, J. P.: Some behavioral and biochemical effects of fenfluramine HCl on the central nervous system. Pharmacologist 11 264 (1969)
Ziance, R. J., Sipes, I. G., Kinnard, W. J., Buckley, J. P.: Central nervous system effects of fenfluramine hydrochloride. J. Pharmacol. exp. Ther. 180, 110–117 (1972)
Author information
Authors and Affiliations
Additional information
Supported by C.N.R. grant N. 75.00620.04.115.2380
Rights and permissions
About this article
Cite this article
Carruba, M.O., Picotti, G.B., Zambotti, F. et al. Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes. Naunyn-Schmiedeberg's Arch. Pharmacol. 298, 1–5 (1977). https://doi.org/10.1007/BF00510979
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00510979